Papillary Muscle Rupture as a Complication of Barlow’s Disease

Main Article Content

Ile Kuzmanoski
Aleksandra Georgieva
Ana Chelikikj
Valentina Andova

Abstract

INTRODUCTION: Mitral regurgitation (MR) is the second most common valvulopathy worldwide, which can be divided into primary and secondary. According to Carpentier’s classification, the primary MR is further divided into three types. Type II, which includes Barlow’s disease, is described as excessive mobility of the mitral valve (MV) leaflets. Morbus Barlow is a common form of degenerative disease, with an incidence of 2–3% of the general population. Echocardiography plays an important role in its diagnosis. It is a usually benign condition, with only a few severe complications.


CASE REPORT: A 75-year-old male with a history of MR, for more than 10 years. On admission, the patient presented with severe fatigue and dyspnea with signs of heart failure and pleural effusion. On auscultation, a systolic murmur was noted, on all the precordium. The ECG revealed sinus rhythm with HR of 71/min and intermittent ventricular extrasystoles. An immediate transthoracic echocardiography (TTE) was performed showing myxomatous degeneration of both MV leaflets and a prolapse of the posterior leaflet. A severe MR was detected with a presumption of papillary muscle rupture (PMR). It also revealed enlarged left atrium and ventricle (LVEDd - 67 mm and LA - 46 mm), with preserved systolic function (EF~54%) and tricuspid regurgitation accompanied by pulmonary hypertension. The laboratory analyses were within normal ranges. The patient was transferred to a cardiovascular surgery clinic, where an immediate MV repair was performed.


CONCLUSION: Barlow’s disease is a common echocardiography finding. Although a benign condition, it can rarely present with serious complications such as PMR, ventricular arrhythmias, and even sudden cardiac death. Echocardiography is the first imaging used for the detection of Barlow’s disease and other MV diseases. Early recognition and confirmation with TTE or transesophageal echocardiography, plays also an appropriate treatment, play a key role in patient survival and overall prognosis.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Kuzmanoski I, Georgieva A, Chelikikj A, Andova V. Papillary Muscle Rupture as a Complication of Barlow’s Disease. SEE J Cardiol [Internet]. 2022 Nov. 20 [cited 2024 Apr. 23];3(1):15-7. Available from: https://seejca.eu/index.php/seejca/article/view/6035
Section
Cardiovascular Imaging

References

Van Wijngaarden AL, Kruithof BP, Vinella T, Barge-Schaapveld DQ, Marsan NA. Characterization of degenerative mitral valve disease: Differences between fibroelastic deficiency and Barlow’s Disease. J Cardiovasc Dev Dis. 2021;8(2):23. https://doi.org/10.3390/jcdd8020023 PMid:33671724 DOI: https://doi.org/10.3390/jcdd8020023

Filsoufi F, Carpentier A. Principles of reconstructive surgery in degenerative mitral valve disease. Semin Thorac Cardiovasc Surg. 2007;19(2):103-10. https://doi.org/10.1053/j.semtcvs.2007.04.003 PMid:17870003 DOI: https://doi.org/10.1053/j.semtcvs.2007.04.003

Milioglou I, Janko MR, Ul Hassan H, ElHaq M, Filby SJ, Pelletier MP. Idiopathic posterior papillary muscle rupture; A case report. BMC Cardiovasc Disord. 2022;22(1):151. https://doi.org/10.1186/s12872-022-02570-4 PMid:35387586 DOI: https://doi.org/10.1186/s12872-022-02570-4

Russo A, Suri RM, Grigioni F, Roger VL, Oh JK, Mahoney DW, et al. Clinical outcome after surgical correction of mitral regurgitation due to papillary muscle rupture. Circulation. 2008;118(15):1528-34. https://doi.org/10.1161/CIRCULATIONAHA.107.747949 PMid:18809799 DOI: https://doi.org/10.1161/CIRCULATIONAHA.107.747949

Suri RM, Schaff HV, Dearani JA, Sundt TM, Daly RC, Mullany CJ, et al. Recovery of left ventricular function after surgical correction of mitral regurgitation caused by leaflet prolapse. J Thorac Cardiovasc Surg. 2009;137(5):1071-6. https://doi.org/10.1016/j.jtcvs.2008.10.026 PMid:19379969 DOI: https://doi.org/10.1016/j.jtcvs.2008.10.026

Samman B, Korr KS, Katz AS, Parisi AF. Pitfalls in the diagnosis and management of papillary muscle rupture: A study of four cases and review of the literature. Clin Cardiol. 1995;18(10):591-6. https://doi.org/10.1002/clc.4960181013 PMid:8785907 DOI: https://doi.org/10.1002/clc.4960181013

Lawrie GM. Barlow disease: Simple and complex. J Thorac Cardiovasc Surg. 2015;150(5):1078-81. https://doi.org/10.1016/j.jtcvs.2015.09.030 PMid:26546198 DOI: https://doi.org/10.1016/j.jtcvs.2015.09.030

Vincelj J, Biočić S, Udovičić M, Sičaja M, Jurinjak SJ. Role of echocardiography in diagnosis and management of complete papillary muscle rupture caused by myocardial infarction. Med Glas (Zenica). 2015;13(2):133-8. https://doi.org/10.17392/793-15 PMid:26276650

Vergara P, Altizio S, Falasconi G, Pannone L, Gulletta S, Bella PD. Electrophysiological substrate in patients with Barlow’s disease. Arrhythm Electrophysiol Rev. 2021;10(1):33-7. https://doi.org/10.15420/aer.2020.29 PMid:33936741 DOI: https://doi.org/10.15420/aer.2020.29

Nastevska EG, Kotlar I, Chelikikj A, Petrovski Z, Karanfilova VA. Papillary muscle rupture as a complication of acute myocardial infarction. Knowl Int J. 2021;44(2):117-21.

Most read articles by the same author(s)